NY-ESO-1 expression in synovial sarcoma and other mesenchymal tumors: significance for NY-ESO-1-based targeted therapy and differential diagnosis

A promising targeted therapy against NY-ESO-1 (CTAG 1B) using genetically modified T-cells in synovial sarcomas was recently demonstrated in a clinical trial at the NCI. To investigate the role of NY-ESO-1 immunohistochemistry in patient selection and gain better insight into the incidence of NY-ESO...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Mod Pathol
Autori principali: Lai, Jin-Ping, Robbins, Paul F, Raffeld, Mark, Aung, Phyu Phyu, Tsokos, Maria, Rosenberg, Steven A, Miettinen, Markku M, Lee, Chyi-Chia Richard
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2012
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6309776/
https://ncbi.nlm.nih.gov/pubmed/22388761
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/modpathol.2012.31
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi